Advances in the prevention of cardiovascular disease (original) (raw)

CVD prevention in 2014

Nature Reviews Cardiology volume 12, pages 71–73 (2015) Cite this article

Subjects

Prevention of cardiovascular diseases (CVDs), particularly atherosclerosis, remains a priority on the global health agenda. A healthy lifestyle at both individual and population levels, combined with pharmacological treatment of CVD risk factors, is recommended. In this Year in Review article, we discuss the major advances in CVD prevention in 2014.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$189.00 per year

only $15.75 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: Five combined low-risk behaviours and the population-preventable proportions of myocardial infarction.

The alternative text for this image may have been generated using AI.

References

  1. Stone, N. J. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 1, 2889–2934 (2014).
    Article Google Scholar
  2. Saposnik, G. Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get With The Guidelines—Stroke 2003 to 2012. Stroke 45, 3343–3351 (2014).
    Article CAS Google Scholar
  3. Pope, C. A. et al. Relationships between fine particulate air pollution, cardiometabolic disorders and cardiovascular mortality. Circ. Res. http://dx.doi.org/10.1161/CIRCRESAHA.116.305060.
  4. Wong, N. D. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat. Rev. Cardiol. 11, 276–289 (2014).
    Article Google Scholar
  5. Van Buren, D. J. & Tibbs, T. L. Lifestyle interventions to reduce diabetes and cardiovascular disease risk among children. Curr. Diab. Rep. 14, 557 (2014).
    Article Google Scholar
  6. Akesson, A., Larsson, S. C., Discacciati, A. & Wolk, A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study. J. Am. Coll. Cardiol. 64, 1299–1306 (2014).
    Article Google Scholar
  7. Chrysant, S. G. & Chrysant, G. S. Future of polypill use for the prevention of cardiovascular disease and strokes. Am. J. Cardiol. 114, 641–645 (2014).
    Article Google Scholar
  8. Bittencourt, M. S. et al. Polypill therapy, subclinical atherosclerosis, and cardiovascular events Implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 63, 434–443 (2014).
    Article Google Scholar
  9. Kotseva, K. et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high risk subjects in general practice: cross-sectional survey in 12 European countries. Eur. J. Cardiovasc. Prev. Rehabil. 17, 530–540 (2010).
    Article Google Scholar
  10. Jennings, C. et al. Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial. Eur. Heart J. 35, 1411–1420 (2014).
    Article CAS Google Scholar

Download references

Acknowledgements

N.S. is affiliated faculty at the School of Population & Public Health, University of British Columbia, Vancouver, BC, Canada.

Author information

Authors and Affiliations

  1. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, PO Box 81465-1148, Isfahan, Iran
    Nizal Sarrafzadegan
  2. Canadian Cancer Society, School of Population & Public Health, University of British Columbia, Room 138–2206 East Mall, Vancouver, V6T 1Z3, BC, Canada
    Carolyn Gotay

Authors

  1. Nizal Sarrafzadegan
  2. Carolyn Gotay

Corresponding author

Correspondence toNizal Sarrafzadegan.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

About this article

Cite this article

Sarrafzadegan, N., Gotay, C. Advances in the prevention of cardiovascular disease.Nat Rev Cardiol 12, 71–73 (2015). https://doi.org/10.1038/nrcardio.2014.209

Download citation

This article is cited by